SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950103-20-011723
Filing Date
2020-06-15
Accepted
2020-06-15 21:47:05
Documents
2
Period of Report
2020-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 dp130270_3-hite.html 3  
1 FORM 3 dp130270_3-hite.xml 3 5390
2 EXHIBIT 24.1 dp130270_ex2401.htm EX-24.1 6245
  Complete submission text file 0000950103-20-011723.txt   12973
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Issuer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACCELERON PHARMA INC. 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Hite Christopher (Reporting) CIK: 0001814238 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39329 | Film No.: 20964857